National Research Corporation (NASDAQ:NRCIA) major shareholder K/I/E/Trust Under Agreement 3/ sold 500 shares of the firm’s stock in a transaction on Monday, October 30th. The stock was sold at an average price of $38.00, for a total value of $19,000.00. Following the completion of the transaction, the insider now owns 5,649,488 shares in the company, valued at $214,680,544. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

K/I/E/Trust Under Agreement 3/ also recently made the following trade(s):

  • On Friday, October 27th, K/I/E/Trust Under Agreement 3/ sold 13,821 shares of National Research Corporation stock. The stock was sold at an average price of $38.00, for a total value of $525,198.00.
  • On Wednesday, October 25th, K/I/E/Trust Under Agreement 3/ sold 2,127 shares of National Research Corporation stock. The stock was sold at an average price of $38.00, for a total value of $80,826.00.
  • On Monday, October 23rd, K/I/E/Trust Under Agreement 3/ sold 267 shares of National Research Corporation stock. The stock was sold at an average price of $38.00, for a total value of $10,146.00.
  • On Thursday, October 19th, K/I/E/Trust Under Agreement 3/ sold 109,000 shares of National Research Corporation stock. The stock was sold at an average price of $37.00, for a total value of $4,033,000.00.

The firm also recently announced a quarterly dividend, which was paid on Friday, October 13th. Investors of record on Friday, September 29th were issued a $0.10 dividend. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.07%. National Research Corporation’s dividend payout ratio is presently 76.92%.

ILLEGAL ACTIVITY WARNING: This news story was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://theolympiareport.com/2017/11/02/national-research-corporation-nrcia-major-shareholder-sells-19000-00-in-stock.html.

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Strs Ohio raised its holdings in shares of National Research Corporation by 49.6% in the 3rd quarter. Strs Ohio now owns 18,100 shares of the business services provider’s stock worth $682,000 after acquiring an additional 6,000 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of National Research Corporation by 252.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,090 shares of the business services provider’s stock worth $244,000 after acquiring an additional 6,508 shares during the last quarter. State Street Corp raised its holdings in shares of National Research Corporation by 12.2% in the 2nd quarter. State Street Corp now owns 157,748 shares of the business services provider’s stock worth $4,241,000 after acquiring an additional 17,163 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of National Research Corporation by 55.6% in the 2nd quarter. Goldman Sachs Group Inc. now owns 19,467 shares of the business services provider’s stock worth $524,000 after acquiring an additional 6,955 shares during the last quarter. Finally, Hillsdale Investment Management Inc. acquired a new stake in shares of National Research Corporation in the 2nd quarter worth about $729,000. Institutional investors own 28.89% of the company’s stock.

Separately, Zacks Investment Research lowered National Research Corporation from a “buy” rating to a “hold” rating in a research report on Saturday, August 12th.

National Research Corporation Company Profile

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Receive News & Ratings for National Research Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.